The role of anti-HLA antibodies in hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 11, 2011, Pages 1585-1588

  Focosi, Daniele ^a   Zucca, Alessandra ^a   Scatena, Fabrizio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Anti HLA antibodies; Hematopoietic stem cell transplantation; Luminex; Mismatch

Indexed keywords

HLA ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; GRAFT FAILURE; GRAFT REJECTION; HISTOINCOMPATIBILITY; HLA MATCHING; HUMAN; NONHUMAN; ORGAN DONOR; SHORT SURVEY;

EID: 80054858842     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.06.004     Document Type: Review

References (25)

1. Claas F. Clinical relevance of circulating donor-specific HLA antibodies. Curr Opin Organ Transplant 2010, 15:462-466.
2. Lefaucheur C., Suberbielle-Boissel C., Hill G., et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol 2009, 162:1-12.
3. van den Berg-Loonen E., Billen E., Voorter C., et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008, 85:1086-1090.
4. Storb R. B cells versus T cells as primary barrier to hematopoietic engraftment in allosensitized recipients. Blood 2009, 113:1205.
5. Gabbianelli M., Boccoli G., Petti S., et al. Expression and in-vitro modulation of HLA antigens in ontogenic development of human hemopoietic system. Ann N Y Acad Sci 1987, 511:138-147.
6. Gabbianelli M., Boccoli G., Cianetti L., Russo G., Testa U., Peschle C. HLA expression in hemopoietic development. Class I and II antigens are induced in the definitive erythroid lineage and differentially modulated by fetal liver cytokines. J Immunol 1990, 144:3354-3360.
7. Robinson J., Sieff C., Delia D.E., PA, Greaves M. Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation. Nature 1981, 289:68-71.
8. Sparrow R., Williams N. The pattern of HLA-DR and HLA-DQ antigen expression on clonable subpopulations of human myeloid progenitor cells. Blood 1986, 67:379-384.
9. Ottmann O., Nocka K., Moore M., Pelus L. Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells. Leukemia 1988, 2:677-686.
10. Terasaki P., Mickey M., Singal D., Mittal K., Patel R. Serotyping for homotransplantation. XX. Selection of recipients for cadaver donor transplants. N Engl J Med 1968, 279:1101-1103.
11. Anasetti C., Amos D., Beatty P.G., et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989, 320:197-204.
12. Mattsson J., Nordlander A., Remberger M.U., et al. Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection. Bone Marrow Transplant 2010, 45:235-238.
13. Xu H., Chilton P., Tanner M., et al. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood 2006, 108:3611-3619.
14. Nagata S., Okano S., Yonemitsu Y.N., et al. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice. Transplantation 2006, 82:689-698.
15. Taylor P., Ehrhardt M., Roforth M., et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007, 109:1307-1315.
16. Spellman S., Bray R., Rosen-Bronson S., et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010, 115:2704-2708.
17. Ciurea S., de Lima M., Cano P., et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009, 88:1019-1024.
18. Leffell M., Cao K., Coppage M., et al. Incidence of humoral sensitization in HLA partially mismatched hematopoietic stem cell transplantation. Tissue Antigens 2009, 74:494-498.
19. Braun N., Faul C., Wernet D., et al. Successful transplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto protein A. Transplantation 2000, 69:1742-1744.
20. Narimatsu H., Wake A., Miura Y., et al. Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion. Bone Marrow Transplant 2005, 36:555-556.
21. Takanashi M, Fujiwara K, Tanaka H, Satake MN, K. The impact of HLA antibodies on engraftment of unrelated cord blood transplants. Transfusion. 2008;48:791-793.
22. Gutman J., McKinney S., Pereira S., et al. Prospective monitoring for alloimmunization in cord blood transplantation: " virtual crossmatch" can be used to demonstrate donor-directed antibodies. Transplantation 2009, 87:415-418.
23. Takanashi M., Atsuta Y., Fujiwara K., et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010, 116:2839-2846.
24. Kataoka K., Yamamoto G., Nannya Y., et al. Successful engraftment following HLA-mismatched cord blood transplantation for patients with anti-HLA Abs. Bone Marrow Transplant 2008, 42:129-130.
25. Uchiyama M., Ikeda T. Successful engraftment following umbilical cord blood transplantation for patients with HLA antibody with or without corresponding HLA in the transplanted cord blood. Bone Marrow Transplant 2010, 45:199-200.